Insect neuropeptide antagonist. Part II. Synthesis and biological activity of backbone cyclic and precyclic PBAN antagonists

被引:14
|
作者
Zeltser, I
Ben-Aziz, O
Schefler, I
Bhargava, K
Altstein, M
Gilon, C [1 ]
机构
[1] Hebrew Univ Jerusalem, Dept Organ Chem, IL-91904 Jerusalem, Israel
[2] Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel
来源
JOURNAL OF PEPTIDE RESEARCH | 2001年 / 58卷 / 04期
关键词
backbone cyclization; cycloscan; insect neuropeptides; neuropeptide antagonists; PBAN; ring-chemistry library; ring-size library;
D O I
10.1034/j.1399-3011.2001.00914.x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new approach for the design and synthesis of pheromone biosynthesis activating neuropeptide (PBAN) agonists and antagonists using the backbone cyclization and cycloscan concepts is described. Two backbone cyclic (BBC) libraries were synthesized: library I (Ser library) was based on the active C-terminal hexapeptide sequence Tyr-Phe-Ser-Pro-Arg-Leu-NH2 Of PBAN1-33NH(2); whereas library II (D-Phe library) was based on the sequence of the PBAN lead linear antagonist Arg-Tyr-Phe-D-PhePro-Arg-Leu-NH2. In both libraries the Pro residue was replaced by the BBC building unit N-alpha-(omega -aminoalkyl) Gly having various lengths of alkyl chain. The peptides of the two libraries were tested for agonistic and antagonistic activity. Four precyclic peptides based on two of the BBC antagonists were also synthesized; their activity revealed that a negative charge at the N-terminus of the peptide abolished antagonistic activity. We also describe the use of the reagent SiCl(3)l for selective deprotection of the Boc group from the building unit prior to on-resin amino-end to backbone-nitrogen (AE-BN) cyclization, during solid-phase synthesis with Fmoc chemistry.
引用
收藏
页码:275 / 284
页数:10
相关论文
共 6 条
  • [1] Backbone cyclic peptidomimetic superantigen antagonists: Synthesis and biological activity
    Glukhov, Evgenia
    Arad, Gila
    Levy, Revital
    Hazan, Karina
    Gazal, Sharon
    Kaempfer, Raymond
    Gilon, Chaim
    [J]. PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 181 - 182
  • [2] Backbone cyclic peptidomimetic superantigen antagonists: Synthesis and biological activity
    Gluchov, I
    Arad, G
    Levy, R
    Kaempfer, R
    Gilon, C
    [J]. BIOPOLYMERS, 2003, 71 (03) : 379 - 379
  • [3] Reactions with α,β-spiroepoxy-alkanones.: Part II.: Uses of spirooxiranes for the synthesis of condensed heterocycles with potential biological activity
    Yousif, NM
    Fahmy, AFM
    Amine, MS
    Gad, FA
    Syed, HH
    [J]. PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1998, 133 : 13 - 20
  • [4] Novel 1β-Methylcarbapenems Having Cyclic Sulfonamide Moieties: Synthesis and Evaluation of in-vitro Biological Activity - Part II
    Kim, Seong Jong
    Cho, Jung-Hyuck
    Oh, Chang-Hyun
    [J]. ARCHIV DER PHARMAZIE, 2009, 342 (09) : 528 - 532
  • [5] Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of π*-π* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT1 non-peptide antagonists
    Polevaya, L
    Mavromoustakos, T
    Zoumboulakis, P
    Grdadolnik, SG
    Roumelioti, P
    Giatas, N
    Mutule, I
    Keivish, T
    Vlahakos, DV
    Iliodromitis, EK
    Kremastinos, DT
    Matsoukas, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (06) : 1639 - 1647
  • [6] Design, synthesis and biological evaluation of cyclic Angiotensin II analogues with 3,5 side-chain bridges: Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonists
    Roumelioti, P
    Polevaya, L
    Zoumpoulakis, P
    Giatas, N
    Mutule, I
    Keivish, T
    Zoga, A
    Vlahakos, D
    Iliodromitis, E
    Kremastinos, D
    Grdadolnik, SG
    Mavromoustakos, T
    Matsoukas, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (18) : 2627 - 2633